sentiment firm estim lower
sentiment firm lower estim think sentiment firm
ge
howev investor sensit insur
perspect compani view world lower
estim manag move urgenc monet asset
remov core bear thesi point liquid proce
use off-set liabil drive earn growth think ge
remain battleground expect stock rang bound ahead
upsid broader
power margin surpris posit guidanc neg
flat better investor expect neg head
call power segment margin guidanc posit better
expect cs model loss rais power margin
underli compar loss cs estim
underli indirect hq cost help lift margin near-
term ultim think fixed/ manufactur cost reduct need
address ge note abil repurpos footprint
view remain ground sum-of-the-part sotp valuat
remain rang /- rang greater compani
cover support view stock remain rang bound
tp maintain tp base ep
estim line ge sotp valu tp
equat yield vs peer risk includ
chang power/ aviat fundament volatil relat gener
legaci liabil
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
ge global industri compani product servic
rang aircraft engin power gener oil ga
product equip medic imag financ industri
profit tax
chang work capit
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
blue-ski valu base blue sky ep
estim scenario assum power sale
continu declin compani continu de-lever
grey-ski valu base grey sky ep
estim scenario ge power sale declin
compound-annual-growth-rate power margin achiev
scenario compani continu de-lever balanc
 close
ge forest industri net
disposit exclud impact suppli chain financ program
restructur aviat expect flat y/i power renew
healthcar expect headwind includ progress collect
renew separ cost incent compens healthcar legal
settlement pension power
outlook includ posit acceler sever headwind
begin abat power expect return profit work capit
signific driver segment improv revers cycl
expect keep renew neg territori impact suppli
chain financ transit extend cash restructur decreas
significantli corpor power
corpor
bhge dividend
declin line
significantli better
better neg
flat grow
bhge dividend
declin line
bhge dividend
declin line
manag note compani manag ep provid outlook
serv guidepost investor adjust ep guid vs
oper improv off-set disposit ge capit asset plan
reduct interest/ tax two primari offset adjust ep
restructur impact non-oper benefit cost impact
result could also impact de-consolid bhge ownership drop
mtm equiti disposit gain loss
figur outlook segment
significantli better
flat expand
better neg
flat grow
grid includ power
biopharma includ exclud
exclud tax reform impact adjust asset plan reduct
segment face realiti market focu improv project
execut reduc cost structur target cost year
includ power hq compani take disciplin approach
project emphas profit market share gain place respons
project execut team advoc project
ge expect power return profit driven hdgt new unit margin
expans improv transact servic howev free cash flow forecast
vs owe headwind progress collect project cost
segment benefit strong market fundament includ continu growth
commerci freight traffic healthi load factor jet fuel deflat militari
market global defens spend forecast compani
robust backlog y/i forecast engin instal base
leap engin product project reach unit unit
break-even cost-out remain track compani also plan
move engin militari
margin forecast vs
impact cfm/leap mix partial off-set transit engin
resourc company-fund customer-fund program compani
expect off-set headwind enter servic
renew lead onshor oem expect continu unit
growth driven cycl despit strong top-line forecast margin expect
owe headwind alstom jv legaci project tariff
custom settlement addit progress collect drive neg forecast
segment opportun cost-out delay product
ge see revenu upsid strong backlog new product pipelin healthi
off-shore market off-shore expect off-set volum declin onshor post-ptc
healthcar perform expect remain stabl eu
variabl emerg market biopharma includ segment guidanc
includ mid-singl digit organ revenu growth margin expans forecast
vs biopharma separ cost suppli chain financ transit
compens time forecast higher incom lower
restructur despit biopharma divestitur higher cash tax
segment focus becom smaller simpler manag risk meet
financi target debt equiti break-even net incom parent
support expect like albeit less order
support insur statutori fund manag continu evalu option
de-risk insur portfolio
corpor transit role support enabl busi
transfer process peopl segment expect gross cost
net corpor cost forecast vs due
primarili time cost action well interest bhge pension
action expect result corpor expens
compani mention price
